Tearsheet
Investment Highlights Market Valuation Price Chart About CI Interactive Breakdown Better Bets vs. CI Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Cigna (CI)

Market Price (10/15/2025): $302.8 | Market Cap: $82.0 Bil
Sector: Health Care | Industry: Health Care Services

Cigna (CI)

Market Price (10/15/2025): $302.8
Market Cap: $82.0 Bil
Sector: Health Care
Industry: Health Care Services

Investment Highlights

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 8.1%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.7%, FCF Yield is 7.3%		 Weak multi-year price returns
2Y Excs Rtn is -45%, 3Y Excs Rtn is -72%		 
1 Attractive cash flow generation
CFO LTM is 7.4 Bil, FCF LTM is 6.0 Bil		  
2 Low stock price volatility
Vol 12M is 30%		  
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 8.1%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.7%, FCF Yield is 7.3%
1 Attractive cash flow generation
CFO LTM is 7.4 Bil, FCF LTM is 6.0 Bil
2 Low stock price volatility
Vol 12M is 30%
3 Weak multi-year price returns
2Y Excs Rtn is -45%, 3Y Excs Rtn is -72%

Market Valuation & Key Metrics

CIS&P 500
REVENUE GROWTHVERY GOOD
Rev LTM ($ Bil)254.5
Rev Chg Q18.2%6.1%
Rev Chg LTM24.6%5.2%
Rev Chg 3Y Avg13.2%5.3%
PROFITABILITYVERY POOR
Op Inc LTM ($ Bil)�
CFO LTM ($ Bil)7.4
CFO/Rev LTM2.9%20.3%
Net Inc LTM ($ Bil)5.0
Net Inc Mgn2.0%12.7%
VALUATIONLOW
P/S0.33.2
P/CFO11.015.7
P/FCF13.620.6
P/E16.323.6
STABILITYGOOD
Debt/Equity0.370.21
Cash/Assets0.060.07

CI Stock

Factor Drivers of Stock Movement
The -7.2% change in CI stock from 4/15/2025 to 10/14/2025 was primarily driven by a -37.7% change in the company's P/E Multiple.

415202510142025Change
Stock Price ($)325.41302.13-7.15%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)244384.00254465.004.13%
Net Income Margin (%)1.41%1.98%40.79%
P/E Multiple26.0716.26-37.65%
Shares Outstanding (Mil)275.16270.871.56%
Cumulative Contribution-7.18%

LTM = Last Twelve Months as of date shown
The -12.4% change in CI stock from 10/14/2024 to 10/14/2025 was primarily driven by a -37.8% change in the company's P/E Multiple.

1014202410142025Change
Stock Price ($)344.86302.13-12.39%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)216008.00254465.0017.80%
Net Income Margin (%)1.72%1.98%15.24%
P/E Multiple26.1516.26-37.82%
Shares Outstanding (Mil)281.13270.873.65%
Cumulative Contribution-12.51%

LTM = Last Twelve Months as of date shown
The 7.8% change in CI stock from 10/15/2022 to 10/14/2025 was primarily driven by a 42.0% change in the company's Total Revenues ($ Mil).

1015202210142025Change
Stock Price ($)280.17302.137.84%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)179178.00254465.0042.02%
Net Income Margin (%)3.07%1.98%-35.51%
P/E Multiple16.0616.261.20%
Shares Outstanding (Mil)315.12270.8714.04%
Cumulative Contribution5.71%

LTM = Last Twelve Months as of date shown

Price Returns Compared

 202020212022202320242025Total [1]
Returns
CI Return2%12%47%-8%-6%11%60%
Peers Return14%40%4%-6%-29%2%13%
S&P 500 Return16%27%-19%24%23%13%103%

Monthly Win Rates [3]
CI Win Rate33%50%83%42%50%67% 
Peers Win Rate52%57%52%45%42%53% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
CI Max Drawdown-36%-7%-5%-26%-10%-4% 
Peers Max Drawdown-32%-5%-15%-22%-32%-29% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: ELV, HUM, CNC, MOH, CVS. See CI Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/14/2025 (YTD)

Downturns Compared

Unique KeyEventCIS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-28.5%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven39.8%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven262 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-41.6%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven71.1%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven295 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-35.7%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven55.5%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven644 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-84.4%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven539.0%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven1518 days1480 days


How Low Can It Go?

Cigna's stock fell -28.5% during the 2022 Inflation Shock from a high on 12/12/2022. A -28.5% loss requires a 39.8% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Cigna (CI)

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Better Bets than Cigna (CI)

 CIBetter Performance than CI
MetricValueIndustry (Health Care Services)
Rev Chg LTM24.6%HIMS (88.7%)
Rev Chg 3Y Avg13.2%HIMS (76.3%), PRVA (17.6%), VCYT (21.3%), PGNY (27.7%), SDGR (13.6%)
CFO/Rev LTM2.9%LH (12.6%), DGX (15.9%), HIMS (13.0%), DVA (14.1%), CHE (14.7%)
FCF/Rev LTM2.4%LH (9.4%), DGX (11.6%), HIMS (5.9%), DVA (9.8%), CHE (12.7%)
Total Yield8.1%CVS (8.6%), DVA (8.7%), CON (66.2%)
 CIBetter Performance than CI
MetricValueAll Other Sectors
Rev Chg LTM24.6%NVDA (71.6%), AVGO (28.0%), PLTR (38.8%), AMD (27.2%), MU (48.9%)
Rev Chg 3Y Avg13.2%NVDA (92.0%), AVGO (24.0%), JPM (13.5%), MA (13.5%), PLTR (25.7%)
CFO/Rev LTM2.9%NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM2.4%NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), GOOGL (18.0%), META (30.7%)
Total Yield8.1%XOM (9.9%), BABA (38.7%), WFC (9.5%), CVX (9.7%), TM (2181.5%)

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Day 10 of Gains Streak for Cigna Stock with 13% Return (vs. 11% YTD) [8/20/2025]Notification 
2Day 9 of Gains Streak for Cigna Stock with 12% Return (vs. 10% YTD) [8/19/2025]Notification 
3Day 8 of Gains Streak for Cigna Stock with 11% Return (vs. 9.1% YTD) [8/18/2025]Notification 
4Day 7 of Gains Streak for Cigna Stock with 10% Return (vs. 8.6% YTD) [8/15/2025]Notification 
5Will You Be Comfortable Buying Cigna Stock?Return 
6Is Wall Street Undervaluing CI Stock?Actionable 
7Day 8 of Loss Streak for Cigna Stock with -9.6% Return (vs. 11% YTD) [7/15/2025]  
8Day 7 of Loss Streak for Cigna Stock with -9.4% Return (vs. 11% YTD) [7/14/2025]  
9Day 6 of Loss Streak for Cigna Stock with -9.3% Return (vs. 11% YTD) [7/11/2025]  
10CI Dip Buy Analysis  
11ARTICLES  
12S&P 500 Movers | Winners: HUM, CNC, CI | Losers: PLTR, LVS, WYNN October 3rd, 2025
13CI Stock Up 13% after 10-Day Win Streak August 21st, 2025
14CI Stock Up 12% after 9-Day Win Streak August 20th, 2025
15CI Stock Up 11% after 8-Day Win Streak August 19th, 2025
16CI Stock Up 10% after 7-Day Win Streak August 16th, 2025
Title
0DASHBOARDS
1S&P 500 Movers | Winners: HUM, CNC, CI | Losers: PLTR, LVS, WYNN
2CI Stock Up 13% after 10-Day Win Streak
3CI Stock Up 12% after 9-Day Win Streak
4CI Stock Up 11% after 8-Day Win Streak
5CI Stock Up 10% after 7-Day Win Streak
6ARTICLES
7Day 10 of Gains Streak for Cigna Stock with 13% Return (vs. 11% YTD) [8/20/2025]
8Day 9 of Gains Streak for Cigna Stock with 12% Return (vs. 10% YTD) [8/19/2025]
9Day 8 of Gains Streak for Cigna Stock with 11% Return (vs. 9.1% YTD) [8/18/2025]
10Day 7 of Gains Streak for Cigna Stock with 10% Return (vs. 8.6% YTD) [8/15/2025]
11Will You Be Comfortable Buying Cigna Stock?
12Is Wall Street Undervaluing CI Stock?
13Day 8 of Loss Streak for Cigna Stock with -9.6% Return (vs. 11% YTD) [7/15/2025]
14Day 7 of Loss Streak for Cigna Stock with -9.4% Return (vs. 11% YTD) [7/14/2025]
15Day 6 of Loss Streak for Cigna Stock with -9.3% Return (vs. 11% YTD) [7/11/2025]
16CI Dip Buy Analysis

Trade Ideas

Select past trade ideas related to CI and Health Care Services.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy09302025ADMAADMA BiologicsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		2.0%2.0%-4.6%
REGN_9302025_Dip_Buyer_ValueBuy09302025REGNRegeneron PharmaceuticalsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		1.8%1.8%-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG09262025HAEHaemoneticsDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap		3.3%3.3%-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025WATWatersMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		10.7%10.7%-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper09052025ISRGIntuitive SurgicalMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-6.5%-6.5%-8.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy09302025ADMAADMA BiologicsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		2.0%2.0%-4.6%
REGN_9302025_Dip_Buyer_ValueBuy09302025REGNRegeneron PharmaceuticalsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		1.8%1.8%-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG09262025HAEHaemoneticsDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap		3.3%3.3%-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025WATWatersMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		10.7%10.7%-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper09052025ISRGIntuitive SurgicalMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-6.5%-6.5%-8.0%

See Trefis Trade Ideas for more.

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1UAMYUnited States Antimony100.8%887.0%
2BITFBitfarms69.7%295.3%
3NVTSNavitas Semiconductor61.6%252.1%
4ASPIASP Isotopes58.0%210.2%
5UUUUEnergy Fuels49.1%411.3%
6GLUEMonte Rosa Therapeutics43.8%52.9%
7SSIISS Innovations International34.1%15.2%
8METCRamaco Resources34.0%439.5%
9MPMP Materials33.7%532.4%
10ORKAOruka Therapeutics33.6%41.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1BNTBrookfield Wealth Solutions-33.2%18.5%
2BNBrookfield-33.0%18.9%
3VGVenture Global-30.2% 
4ALABAstera Labs-23.8%22.0%
5HELEHelen Of Troy-23.3%-65.4%
6CORTCorcept Therapeutics-20.2%43.1%
7USNAUsana Health Sciences-19.4%-40.9%
8SRRKScholar Rock-19.2%-26.2%
9TASKTaskUs-18.8%-18.1%
10BBBYBed Bath & Beyond-18.1% 

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1WOLFWolfspeed1000.7%389.2%
2QUREuniQure297.4%233.9%
3UAMYUnited States Antimony244.6%887.0%
4LACLithium Americas214.1%238.4%
5RGTIRigetti Computing192.1%267.8%
6USARUSA Rare Earth173.3%125889.9%
7PLUGPlug Power158.0%90.1%
8FLNCFluence Energy149.7%16.2%
9CLPTClearPoint Neuro148.6%69.2%
10SESSES AI140.2%44.7%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1ANGXAngel Studios-53.8% 
2REXREX American Resources-46.2%57.7%
3VGVenture Global-34.0% 
4LDIloanDepot-33.8%46.6%
5FLYFirefly Aerospace-31.4% 
6ALABAstera Labs-30.2%22.0%
7FWRDForward Air-29.4%-34.3%
8USNAUsana Health Sciences-29.1%-40.9%
9IDTIDT-28.9%-0.4%
10PGYPagaya Technologies-28.8%221.4%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1UAMYUnited States Antimony100.8%887.0%
2BITFBitfarms69.7%295.3%
3NVTSNavitas Semiconductor61.6%252.1%
4ASPIASP Isotopes58.0%210.2%
5UUUUEnergy Fuels49.1%411.3%
6GLUEMonte Rosa Therapeutics43.8%52.9%
7SSIISS Innovations International34.1%15.2%
8METCRamaco Resources34.0%439.5%
9MPMP Materials33.7%532.4%
10ORKAOruka Therapeutics33.6%41.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1BNTBrookfield Wealth Solutions-33.2%18.5%
2BNBrookfield-33.0%18.9%
3VGVenture Global-30.2% 
4ALABAstera Labs-23.8%22.0%
5HELEHelen Of Troy-23.3%-65.4%
6CORTCorcept Therapeutics-20.2%43.1%
7USNAUsana Health Sciences-19.4%-40.9%
8SRRKScholar Rock-19.2%-26.2%
9TASKTaskUs-18.8%-18.1%
10BBBYBed Bath & Beyond-18.1% 

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Cigna

Financials

CIELVHUMCNCMOHCVSMedian
NameCigna Elevance.Humana Centene Molina H.CVS Heal. 
Mkt Price302.13350.48261.6136.44194.8979.66228.25
Mkt Cap81.878.931.518.010.4100.555.2
Rev LTM254,465189,254123,110178,19043,413378,960183,722
Op Inc LTM---1,9711,65310,8981,971
FCF LTM6,0105,3372,4391,0804275,9413,888
FCF 3Y Avg8,8035,5763,1753,66464710,4914,620
CFO LTM7,4436,4542,9321,7305378,7604,693
CFO 3Y Avg10,2416,7823,9584,41974513,2345,601

Growth & Margins

CIELVHUMCNCMOHCVSMedian
NameCigna Elevance.Humana Centene Molina H.CVS Heal. 
Rev Chg LTM24.6%10.2%9.9%13.0%16.1%5.0%11.6%
Rev Chg 3Y Avg13.2%8.3%11.3%8.9%12.8%8.1%10.1%
Rev Chg Q18.2%14.0%9.6%22.4%15.7%7.0%14.9%
QoQ Delta Rev Chg LTM4.1%3.3%2.4%5.3%3.7%1.6%3.5%
Op Mgn LTM---1.1%3.8%2.9%2.9%
Op Mgn 3Y Avg---1.9%4.2%3.8%3.8%
QoQ Delta Op Mgn LTM----1.0%-0.3%0.2%-0.3%
CFO/Rev LTM2.9%3.4%2.4%1.0%1.2%2.3%2.3%
CFO/Rev 3Y Avg5.0%3.9%4.0%2.9%2.1%3.8%3.9%
FCF/Rev LTM2.4%2.8%2.0%0.6%1.0%1.6%1.8%
FCF/Rev 3Y Avg4.3%3.2%3.3%2.4%1.9%3.0%3.1%

Valuation

CIELVHUMCNCMOHCVSMedian
NameCigna Elevance.Humana Centene Molina H.CVS Heal. 
Mkt Cap81.878.931.518.010.4100.555.2
P/S0.30.40.30.10.20.30.3
P/EBIT9.89.411.05.26.39.89.6
P/E16.314.720.08.89.219.015.5
P/CFO11.012.210.810.419.511.511.2
Total Yield8.1%8.7%6.4%11.4%10.8%8.6%8.7%
Dividend Yield1.9%1.9%1.4%0.0%0.0%3.4%1.6%
FCF Yield 3Y Avg9.9%5.6%6.3%10.4%3.8%12.5%8.1%
D/E0.40.40.41.00.30.80.4
Net D/E0.3-0.0-0.30.0-0.50.7-0.0

Returns

CIELVHUMCNCMOHCVSMedian
NameCigna Elevance.Humana Centene Molina H.CVS Heal. 
1M Rtn-0.2%12.4%-5.0%9.6%7.7%6.2%7.0%
3M Rtn0.4%4.8%18.3%21.5%-9.2%24.6%11.6%
6M Rtn-7.2%-19.1%-8.1%-41.5%-41.9%18.0%-13.6%
12M Rtn-12.4%-29.9%-0.9%-50.0%-42.7%23.5%-21.1%
3Y Rtn7.8%-22.3%-46.0%-51.0%-44.6%-0.2%-33.5%
1M Excs Rtn1.2%13.8%-5.1%11.2%10.2%8.0%9.1%
3M Excs Rtn-6.8%-3.8%9.8%13.8%-15.9%18.8%3.0%
6M Excs Rtn-30.2%-42.7%-30.4%-65.1%-67.0%-5.3%-36.5%
12M Excs Rtn-27.1%-42.4%-9.4%-64.1%-55.1%9.7%-34.8%
3Y Excs Rtn-72.1%-104.2%-129.0%-133.8%-126.7%-81.5%-115.5%

Financials

$ Mil | FY: 12/312025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q2
Period End3/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/20226/30/2022
Filing Date5/2/20252/27/202510/31/20248/1/20245/2/20242/29/202411/2/20238/3/20235/5/20232/23/202311/3/20228/4/2022
Key Financials Quarterly            
Total Revenue65,50065,71762,77360,47555,41951,08049,03448,61246,46145,75945,19945,389
Ebitda------------
Operating Income------------
Net Income1,3231,4247391,548-2771,0291,4081,4601,2671,1932,7571,557
EPS4.885.132.655.51-0.973.494.794.964.283.839.074.94
Key Financials TTM            
Total Revenue TTM254,465244,384229,747216,008204,145195,187189,866186,031182,808180,031180,021179,178
Ebitda TTM------------
Operating Income TTM------------
Net Income TTM5,0343,4343,0393,7083,6205,1645,3286,6776,7746,7046,6325,496
Growth Rates Quarterly            
Total Revenue Growth18.2%28.7%28.0%24.4%19.3%11.6%8.5%7.1%6.4%0.0%1.9%5.1%
EBITDA Growth------------
Operating Income Growth------------
Net Income Growth577.6%38.4%-47.5%6.0%-121.9%-13.7%-48.9%-6.2%5.8%6.4%70.1%6.1%
Margins Quarterly            
EBITDA Margin------------
Operating Income Margin------------
Net Income Margin2.0%2.2%1.2%2.6%-0.5%2.0%2.9%3.0%2.7%2.6%6.1%3.4%
Cash & Debt            
Total Cash9,0618,2156,7527,8569,5478,7479,54310,4578,8496,8297,8625,175
Total Debt30,44831,97232,80231,89232,76830,93031,14032,73332,54231,09331,57833,381
Net Debt / (Cash)21,38723,75726,05024,03623,22122,18321,59722,27623,69324,26423,71628,206
Cash Flows Quarterly            
FCF from Operations1,9205,212462654,8401,4672,8262,4925,0282,0993,2831,244
Cash Flows TTM            
FCF from Operations TTM7,44310,3636,6189,39811,62511,81312,44512,90211,6548,65610,8329,668
Returns to Shareholders Quarterly            
Dividends412384390392401358362362368334341352
Share Repurchases1,5082,022-09904,0225446241549621,7333,5001,006
Return on Invested Capital (ROIC) Quarterly            
ROIC26.4%25.9%12.7%27.1%1.4%3.4%26.8%27.1%22.0%20.1%46.9%22.3%
Return on Invested Capital (ROIC) TTM            
ROIC TTM25.2%15.9%12.9%16.5%16.6%24.2%25.4%30.6%29.0%28.0%28.2%19.7%

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Evernorth Health Services153,499140,335131,912116,334109,794
Cigna Healthcare51,14844,91144,64341,265 
Other Operations5962,2633,9898,446 
Corporate and Eliminations-9,978-6,991-6,475-5,644-3,588
Net realized investment (losses) gains  198  
Group Disability and Other    5,182
International Markets    5,659
U.S. Medical    36,519
Total195,265180,518174,267160,401153,566


Price Behavior

CI Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta0.440.560.780.180.080.24
Up Beta2.241.121.170.130.190.28
Down Beta-0.151.131.210.14-0.230.01
Up Capture-30%50%-0%9%6%8%
Bmk +ve Days13233574144420
Stock +ve Days11263263130409
Down Capture92%-19%128%53%40%62%
Bmk -ve Days8192952107330
Stock -ve Days10163263121342

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date9302025
Short Interest: Shares Quantity3,562,269
Short Interest: % Change Since 91520259.2%
Average Daily Volume1,523,481
Days-to-Cover Short Interest2.34
Basic Shares Quantity270,867,000
Short % of Basic Shares1.3%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/31/2025-10.2%-9.4%0.9%
5/2/2025-0.1%-0.6%-6.0%
1/30/2025-6.7%-3.3%1.8%
10/31/20240.6%0.7%8.0%
8/1/2024-4.6%-5.6%3.6%
5/2/2024-3.6%-2.8%-3.5%
2/2/20245.4%8.1%9.6%
11/2/20233.1%-4.5%-13.1%
...
SUMMARY STATS   
# Positive111114
# Negative131310
Median Positive2.6%3.8%4.3%
Median Negative-3.9%-3.8%-5.5%
Max Positive7.0%8.1%13.3%
Max Negative-10.9%-9.4%-13.1%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025731202510-Q 6/30/2025
3312025502202510-Q 3/31/2025
12312024227202510-K 12/31/2024
93020241031202410-Q 9/30/2024
6302024801202410-Q 6/30/2024
3312024502202410-Q 3/31/2024
12312023229202410-K 12/31/2023
93020231102202310-Q 9/30/2023
6302023803202310-Q 6/30/2023
3312023505202310-Q 3/31/2023
12312022223202310-K 12/31/2022
93020221103202210-Q 9/30/2022
6302022804202210-Q 6/30/2022
3312022506202210-Q 3/31/2022
12312021224202210-K 12/31/2021
93020211104202110-Q 9/30/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value		Value of
Held Shares		Form
0Eder Noelle KSee Remarks3112025Sell320.009,9443,182,0804,289,920Form

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.